Fondazione MBBM, ASST Monza

Monza 20900

0 studies enrolling now · 1 studies all time

What they study most

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater Than or Equal to (>=)1 and Less Than or Equal to (<=) 30 Years of Age With Relapsed/Refractory Precursor B-cell or T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma — Completed